RSS

Evonik

Evonik outlines new opportunities for drug delivery via advanced parenteral formulations, the positives and the pitfalls. Read more

Opinion

Global CMO Evonik has completed a €36 million expansion of advanced technologies to help boost its manufacturing capabilities across the US and Europe. Read more

News

Evonik outlines new opportunities for drug delivery via advanced parenteral formulations, the positives and the pitfalls. Read more

Opinion

In a press statement from the European Commission, it has been announced that the proposed acquisition of Huber Silica by Evonik has been approved, subject to divestment of some of both companies’ activities relating to precipitated silica. Read more

News